How to improve the cost effectiveness of oncology drug development A commentary on Tan et al. Anti-cancer drug resistance--understanding the mechanisms through the use of integrative genomics and functional RNA interference.
McCabe
Christopher
C
Smyth
John
J
D000970:Antineoplastic Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D023281:Genomics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics* / Q000235:genetics; D034622:RNA Interference / Q000187:drug effects*; D013678:Technology, Pharmaceutical / Q000191:economics*
D000970:Antineoplastic Agents